InsiderClue
Stocks · Health care · Pharmaceutical Preparations

LIGAND PHARMACEUTICALS INC

LGND Clue Score50
United States Fiscal year ends December CIK 0000886163 Results filed 29 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

32
Insider
Date
Role
Action
Shares
Price
Amount
Octavio Espinoza
27 May 2026
Chief Financial Officer
Exercised, kept
972
$52.84
$51.36K
Octavio Espinoza
27 May 2026
Chief Financial Officer
Exercised, kept
764
$63.62
$48.61K
Octavio Espinoza
16 Dec 2025
Chief Financial Officer
Exercised, kept
181
$103.42
$18.72K
Octavio Espinoza
16 Dec 2025
Chief Financial Officer
Exercised, kept
652
$92.65
$60.41K
Octavio Espinoza
16 Dec 2025
Chief Financial Officer
Exercised, kept
285
$63.62
$18.13K
Octavio Espinoza
16 Dec 2025
Chief Financial Officer
Exercised, kept
69
$57.22
$3.95K
Octavio Espinoza
16 Dec 2025
Chief Financial Officer
Exercised, kept
1,194
$52.84
$63.09K
Jason Aryeh
8 Dec 2025
Director
Exercised, kept
2,034
$69.51
$141.38K
Stephen L Sabba
1 Apr 2025
Director
Exercised, kept
2,406
$52.30
$125.83K
John W Kozarich
17 Jan 2025
Director
Exercised, kept
2,406
$52.30
$125.83K
Octavio Espinoza
17 Sep 2024
Chief Financial Officer
Exercised, kept
69
$57.22
$3.95K
Octavio Espinoza
17 Sep 2024
Chief Financial Officer
Exercised, kept
1,417
$80.72
$114.38K
Matthew E Korenberg
16 Sep 2024
President & COO
Exercised, kept
3,340
$60.94
$203.54K
Matthew E Korenberg
16 Sep 2024
President & COO
Exercised, kept
671
$49.99
$33.54K
Matthew E Korenberg
16 Sep 2024
President & COO
Exercised, kept
849
$58.49
$49.66K
Matthew E Korenberg
16 Sep 2024
President & COO
Exercised, kept
914
$55.75
$50.96K
Octavio Espinoza
28 Aug 2024
Chief Financial Officer
Exercised, kept
546
$70.04
$38.24K
Octavio Espinoza
28 Aug 2024
Chief Financial Officer
Exercised, kept
207
$57.22
$11.84K
Jason Aryeh
30 Apr 2024
Director
Exercised, kept
2,406
$52.30
$125.83K
John W Kozarich
24 Apr 2024
Director
Exercised, kept
2,893
$39.35
$113.84K
Todd C Davis
25 Mar 2024
Chief Executive Officer
Exercised, kept
3,556
$66.19
$235.37K
Todd C Davis
25 Mar 2024
Chief Executive Officer
Exercised, kept
2,156
$68.51
$147.71K
Todd C Davis
25 Mar 2024
Chief Executive Officer
Exercised, kept
2,855
$67.24
$191.97K
Todd C Davis
25 Mar 2024
Chief Executive Officer
Exercised, kept
7,448
$46.20
$344.10K
Jason Aryeh
5 Mar 2024
Director
Exercised, kept
2,893
$39.35
$113.84K
John L Higgins
12 Dec 2022
Director
Exercised, kept
20,000
$12.78
$255.60K
John L Higgins
18 Nov 2022
Chief Executive Officer
Exercised, kept
10,000
$12.78
$127.80K
John L Higgins
9 May 2022
Chief Executive Officer
Exercised, kept
8,000
$21.92
$175.36K
Matthew W Foehr
28 May 2021
President and COO
Exercised, kept
1,755
$56.26
$98.74K
John W Kozarich
11 May 2021
Director
Exercised, kept
4,835
$10.12
$48.93K
John W Kozarich
22 Feb 2021
Director
Exercised, kept
2,500
$10.12
$25.30K
Todd C Davis
11 Feb 2021
Director
Exercised, kept
2,474
$195.91
$484.68K
Showing 250 of 377 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 418
Amendments (4/A) skipped 11
Filings about a different issuer 6
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 51
Sales straight out of an exercise 149
Sales at will 85
Transactions with no price 0
Shares from compensation/vesting 2,217,470
Sales filed before the plan box existed 45
History held since 29 Sep 2006